Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries

New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear.

Saved in:
Bibliographic Details
Main Authors: Mills, Mackenzie (Author) , Michaeli, Daniel (Author) , Miracolo, Aurelio (Author) , Kanavos, Panos (Author)
Format: Article (Journal)
Language:English
Published: 13 February 2023
In: BMC health services research
Year: 2023, Volume: 23, Pages: 1-17
ISSN:1472-6963
DOI:10.1186/s12913-023-09095-2
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12913-023-09095-2
Get full text
Author Notes:Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos
Description
Summary:New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear.
Item Description:Gesehen am 17.04.2023
Physical Description:Online Resource
ISSN:1472-6963
DOI:10.1186/s12913-023-09095-2